Clinical Trial Update: Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating methotrexate with glucocorticoids for newly diagnosed acute graft-versus-host disease after donor stem cell transplant has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Graft-versus-host Disease

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• glucocorticoids (glucocorticoids)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Cancer | Phase 2 | Status: COMPLETED